Notably, most of the enhancer-gene relationships we identified have not been previously linked to lymphoid malignancy, yet our results demonstrate that these cognate target genes are essential in all BCP-ALL cases, as shown with the MYB and DCTD genes. This evidence concerns the gene DCTD and acute lymphoblastic leukemia.